Search research articles
Contact Us
Filters
Showing results (41-50 of 238) with videos related to
Page
of 24
Sort By:
Rheumatology (Oxford, England)
|
July 17, 2025
Individualizing non-steroidal anti-inflammatory drug therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis
Mark C Hwang, Seokhun Kim, Shervin Assassi, et al.
The Journal of Rheumatology
|
April 15, 2025
Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies
Elizabeth R Volkmann, Shervin Assassi, Christopher P Denton, et al.
Rheumatology (Oxford, England)
|
October 17, 2024
FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease
Elana J Bernstein, Francesco Boin, Brett Elicker, et al.
Arthritis Care & Research
|
January 15, 2024
A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis
Bochra Jandali, Marka Lyons, Julio Charles, et al.
Rheumatology (Oxford, England)
|
January 3, 2018
Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis
John D Pauling, Gloria Salazar, Hui Lu, et al.
The American Journal of Medicine
|
August 9, 2005
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis
Shervin Assassi, Maureen D Mayes, Terry McNearney, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 17, 2015
Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors
Peng Wei, Yang Yang, Xinjian Guo, et al.
Clinical and Experimental Rheumatology
|
July 12, 2022
High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey
Cosimo Bruni, Lorinda Chung, Anna Maria Hoffmann-Vold, et al.
Journal of Scleroderma and Related Disorders
|
November 15, 2024
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease
Dinesh Khanna, Luke B Evnin, Shervin Assassi, et al.
Frontiers in Immunology
|
November 29, 2023
Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage
Chiara Bellocchi, Xuan Wang, Marka A Lyons, et al.
Page
of 24
Search research articles
Search
Showing results (41-50 of 238) with videos related to
Sort By:
Page
of 24
Rheumatology (Oxford, England)
|
July 17, 2025
Individualizing non-steroidal anti-inflammatory drug therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis
Mark C Hwang, Seokhun Kim, Shervin Assassi, et al.
The Journal of Rheumatology
|
April 15, 2025
Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies
Elizabeth R Volkmann, Shervin Assassi, Christopher P Denton, et al.
Rheumatology (Oxford, England)
|
October 17, 2024
FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease
Elana J Bernstein, Francesco Boin, Brett Elicker, et al.
Arthritis Care & Research
|
January 15, 2024
A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis
Bochra Jandali, Marka Lyons, Julio Charles, et al.
Rheumatology (Oxford, England)
|
January 3, 2018
Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis
John D Pauling, Gloria Salazar, Hui Lu, et al.
The American Journal of Medicine
|
August 9, 2005
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis
Shervin Assassi, Maureen D Mayes, Terry McNearney, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 17, 2015
Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors
Peng Wei, Yang Yang, Xinjian Guo, et al.
Clinical and Experimental Rheumatology
|
July 12, 2022
High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey
Cosimo Bruni, Lorinda Chung, Anna Maria Hoffmann-Vold, et al.
Journal of Scleroderma and Related Disorders
|
November 15, 2024
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease
Dinesh Khanna, Luke B Evnin, Shervin Assassi, et al.
Frontiers in Immunology
|
November 29, 2023
Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage
Chiara Bellocchi, Xuan Wang, Marka A Lyons, et al.
Page
of 24